NASOPHARYNGEAL CARCINOMA (NPC)
Clinical trials for NASOPHARYNGEAL CARCINOMA (NPC) explained in plain language.
Never miss a new study
Get alerted when new NASOPHARYNGEAL CARCINOMA (NPC) trials appear
Sign up with your email to follow new studies for NASOPHARYNGEAL CARCINOMA (NPC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug duo tested to stop throat cancer return
Disease control Not yet recruitingThis study tests whether a new drug, Becotatug vedotin, works better than the standard drug capecitabine to prevent cancer from coming back in people with advanced nasopharyngeal carcinoma. About 218 adults who have already completed initial chemo-radiation will be randomly assig…
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Phase: PHASE2 • Sponsor: Kai Hu • Aim: Disease control
Last updated May 26, 2026 06:58 UTC
-
Proton therapy may offer better outcomes for nasopharyngeal cancer patients
Disease control Not yet recruitingThis study compares two types of radiation therapy for people with nasopharyngeal cancer that hasn't spread. One uses protons, the other uses standard photons. The goal is to see if proton therapy causes fewer side effects and helps people live longer without the cancer coming ba…
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Phase: NA • Sponsor: Guangzhou Concord Cancer Center • Aim: Disease control
Last updated May 26, 2026 06:51 UTC
-
New hope for hard-to-treat nose and throat cancer: experimental drug shows promise
Disease control Not yet recruitingThis study tests a new drug called ivonescimab in 42 adults with advanced nasopharyngeal cancer that has stopped responding to standard treatments like immunotherapy and chemotherapy. The goal is to see if the drug can shrink tumors or slow the cancer's growth. Participants will …
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Phase: PHASE2 • Sponsor: National University Hospital, Singapore • Aim: Disease control
Last updated May 26, 2026 06:48 UTC
-
Immune booster aims to stop Cancer's return in advanced nasopharyngeal cancer
Disease control Not yet recruitingThis study tests whether adding Natural Killer (NK) cells from healthy donors to standard chemoradiotherapy can lower the chance of cancer returning in people with advanced nasopharyngeal cancer. About 31 participants will receive different doses of NK cells to find the safest an…
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Phase: PHASE1, PHASE2 • Sponsor: Singapore General Hospital • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New drug may shield cancer patients from dangerous platelet drop
Disease control Not yet recruitingThis study tests whether the drug hetrombopag can prevent severe low platelet counts caused by chemotherapy in people with nasopharyngeal carcinoma. About 35 patients who had low platelets after their last chemo round will receive hetrombopag during their next cycles. The goal is…
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Phase: PHASE2 • Sponsor: Fujian Cancer Hospital • Aim: Disease control
Last updated May 11, 2026 20:50 UTC
-
New drug duo shows promise for Tough-to-Treat throat cancer
Disease control Not yet recruitingThis study tests whether combining two drugs, scipibaimab and tislelizumab, can shrink tumors or slow cancer growth in people with advanced nasopharyngeal cancer that got worse after standard first treatment. About 37 adults aged 18-75 will receive the combo. The goal is to see h…
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 01, 2026 15:58 UTC
-
Simple procedure may prevent deadly side effect of repeat radiation in nasal cancer patients
Prevention Not yet recruitingThis study tests whether removing a thin layer of tissue (pseudomembrane) from the nose and throat can prevent tissue death caused by repeat radiation in people with recurrent nasopharyngeal cancer. About 40 adults who develop this membrane during or after their second round of r…
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Phase: NA • Sponsor: Jiangxi Provincial Cancer Hospital • Aim: Prevention
Last updated May 22, 2026 14:01 UTC
-
Taurine trial aims to soothe Radiation's painful side effect
Symptom relief Not yet recruitingThis study tests whether the supplement taurine can prevent or reduce severe mouth sores caused by radiation therapy in people with nasopharyngeal cancer. About 130 adults will be randomly assigned to receive taurine or standard care during their radiation treatment. The goal is …
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Symptom relief
Last updated May 26, 2026 06:59 UTC
-
Immune clues in NPC: scientists hunt for better predictors and targets
Knowledge-focused Not yet recruitingThis study looks at how the immune system around nasopharyngeal tumors changes over time, especially after immunotherapy. Researchers will analyze samples from 600 patients to find which immune cells predict treatment success and why some tumors become resistant. The goal is to i…
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Knowledge-focused
Last updated May 26, 2026 06:53 UTC
-
New imaging technique may sharpen cancer staging and immunotherapy predictions
Knowledge-focused Not yet recruitingThis study will test whether two types of PET/CT scans can more accurately stage nasopharyngeal cancer and predict how well patients will respond to immunotherapy before treatment. Researchers will observe 732 adults with newly diagnosed cancer, measuring tumor activity on scans …
Matched conditions: NASOPHARYNGEAL CARCINOMA (NPC)
Sponsor: The First Affiliated Hospital of Xiamen University • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC